© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
388047 |
As an accredited 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Curiosity drives most changes in chemistry, especially in fields as specialized as heterocyclic compound synthesis. Over the last few years, a lot of attention has landed on small, functionalized cores that open doors for new drug development, agrochemical advancement, and material science exploration. Among these, 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine stands out as a genuine workhorse for anyone building libraries of kinase inhibitors, enzyme modulators, or novel heteroaromatic scaffolds.
Nobody expects newcomers to instantly grasp the maze of pyrazolopyrimidine derivatives. Chemical models sometimes seem more like puzzles from another planet than good research tools. This compound finds itself at the intersection of a pyrazole fused to a pyrimidine ring, with a bromine atom sitting right at the 3-position. Such a combination isn’t just for novelty; it shapes the compound’s reactivity and paves the way for selective substitutions during synthesis. The H atom at the 1-position may sound trivial, but it comes with its perks, especially when it comes to coupling reactions or changing the core’s physicochemical profile.
Anybody working in medicinal chemistry will recognize the importance of models that bring enough stability for benchwork but leave room for derivatization. 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine answers that need by keeping the reactive bromine handy for Suzuki, Sonogashira, and Buchwald–Hartwig couplings, making it a useful “hook” for installing a range of groups. In my own work, installing a phenyl or aliphatic moiety at this position often brought about unexpected potency in kinase assay panels.
Purity, melting point, and physical stability tell much more than a catalog’s fine print. Researchers don’t just grab a compound; they judge it by how well it integrates with their workflows and resists ambient moisture or heat. This compound normally appears as an off-white to beige solid, holding up well during storage under dry, cool conditions. A careful approach to packing and handling saves headaches and keeps reactions running smoothly.
Of course, everyone wants clear data. Trusted suppliers test their material with NMR, HPLC, LC-MS, and IR to confirm proper structure and content. Handling a batch of this compound leaves no surprises—what you see is what you get, and a quick TLC run confirms that. From my bench, I noticed the powder easily dissolves in most standard organic solvents—DMF, DMSO, acetonitrile, even dichloromethane to some extent—which cuts prep time and sidesteps solubility headaches.
Combining a halogen on a pyrazolopyrimidine core with a free N-H ushers in new routes for scaffold elaboration. Medicinal chemists know that kinase binders often hinge on heterocyclic frameworks, and this molecule forms a backbone present in several classes of kinase inhibitors. I remember a late night running a Suzuki coupling—this bromo-pyrazolopyrimidine started as the scaffold, and creating a small library from it became almost routine.
It takes no stretch of imagination to see the compound’s appeal for SAR (structure-activity relationship) studies. Researchers attach different groups at the brominated site to track biological activity shifts. Organometallic chemists lean on this core for palladium-catalyzed cross-coupling. In some recent kinase projects, using this molecule sped up early-phase hit validation since analogues could be quickly generated without repeated rounds of raw material synthesis. That’s not just efficiency; it’s smarter science.
Process chemists share stories about how the crystalline nature of many pyrazolopyrimidines, including this one, makes purification by trituration or simple chromatography far less painful than with greasy or highly hygroscopic analogues. Consistent work-up means fewer batch failures and more confidence in the final product. In the context of scale-up, every hour and gram saved counts toward project momentum.
Not all pyrazolopyrimidines perform equally. Substitution pattern alters everything—stability, functional group compatibility, rates of side reactions, and even toxicity profiles. Many analogues skip the bromine for chlorines or keep the aromatic ring unfunctionalized. In practice, bromine turns out to be more than a placeholder. It’s less electron-withdrawing than chlorine yet easier to replace using palladium-catalyzed chemistry. During one campaign on a series of kinase inhibitors, swapping in a bromine led to higher yields and better regioselectivity compared to using the chloro analogue.
Bromine also steers clear of some stubborn dehalogenation issues that dog iodo analogues. This difference is not just theoretical or arcane; hundreds of medicinal chemistry papers single out bromo versions for their cross-coupling reliability. Anyone who’s spent days unraveling “double hit” problems on polychlorinated scaffolds appreciates the smoother ride with brominated precursors, especially as projects near tight deadlines.
Structurally, the H at N-1 may seem humble, but it opens one more channel for modification. N-alkylation or N-arylation can be dialed in with a wider selection of starting materials. Such versatility gets attention from teams looking to diversify libraries or prepare tags for mechanistic studies. Early adopters from both academic and industrial labs keep referencing this adaptability in publications, pointing to the core’s persistent popularity.
Every synthetic chemist faces constraints—budget, time, reliability of starting materials, and, most unavoidable of all, unpredictability in chemical behavior. 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine brings some relief on these fronts. Reliable commercial sources exist, and the supply chain for pyrazolopyrimidine derivatives remains robust, even when niche reagents sometimes fall out of stock unexpectedly.
Green chemistry matters now more than ever. Streamlining processes and minimizing toxic byproducts sit high on the list of priorities for labs everywhere. In comparing brominated pyrazolopyrimidines to other halogenated analogues, it becomes clear that efficient transformations translate to cleaner reactions—lower waste streams, fewer solvent-intensive purifications, and safer working conditions.
I’ve seen process chemists gravitate toward substrates that make single-step syntheses possible. A reliable bromo group at the 3-position means researchers avoid lengthy protecting-group play and cumbersome pre-activation steps. Efficiency compounds over dozens of molecules, nowhere more obvious than in lead optimization campaigns or rapid analogue generation.
Chemical innovation rarely follows a straight path. A platform molecule like 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine puts the power for new discoveries into more hands, not just in big pharma, but in academic start-ups and teaching labs aiming to prove their value. Timing often matters most in research, and access to reliable, functionalized heterocycles shortens cycles of trial and error. The compound does this by providing enough complexity for advanced chemistry while staying accessible for routine benchtop reactions.
It’s worth recognizing that each functional group presents its own quirks. For instance, bromo derivatives—while known for their coupling reactivity—sometimes present compatibility challenges with highly nucleophilic reagents or strong reducing agents. Such context-specific challenges require smart experimental design, and that’s where hands-on experience shines. Consulting peer-reviewed literature helps predict these snags. When it comes to environmental and operator safety, proper ventilation, gloves, and storage in tightly sealed containers address standard concerns without derailing progress.
There’s an ongoing push for even safer, greener halogenations and dehalogenations. Researchers keep tweaking conditions to avoid volatile organic solvents or hazardous bases. It’s encouraging to see ball milling, aqueous-phase chemistry, and biocatalytic strategies show promise even on complex cores like this one.
The gap between academic discovery and industrial application is narrowing, sparked in part by agile access to versatile building blocks. Pockets of research groups are harnessing 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine to push the limits of diversity-oriented synthesis (DOS) or fragment-based drug design (FBDD). Seeing a researcher’s excitement over a productive, high-yielding coupling still feels infectious, even for veterans who’ve witnessed several research cycles and trends.
On the industrial side, speed and reliability drive results more than anything else. Medicinal chemistry teams pressed to identify multiple active compounds in a short window find value in plug-and-play cores like this bromo heterocycle. Since most structural modifications depend on smooth, high-yielding reactions, predictable bromine chemistry becomes a tangible competitive advantage. Trusted supply chains, batch-to-batch consistency, and rapid technical support turn a basic stockroom bottle into a strategic resource.
Recently, contract research organizations (CROs) that serve as partners for global drug developers have recognized the benefits of integrating halogenated heterocycles. These organizations focus on early-phase screening and optimization, where quick supply of such intermediates can often tip the balance between a dead-end and a breakthrough.
Chemistry’s favorite trick is reinventing old ideas with sharper tools and broader know-how. Pyrazolopyrimidine frameworks keep attracting attention from many corners: kinase inhibitor pipelines, environmental sensor development, even emerging areas like light-emitting materials and photovoltaic applications. The bromo variant’s resilience and flexibility position it for wider adoption.
Machine learning and computational chemistry are racing ahead, often working in tandem with seasoned synthetic chemists. Predicting bioactivity, solubility, and physicochemical properties across analogues streamlines selection and synthesis planning. This has made the reliable performance of building blocks like 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine even more critical. Their well-characterized physical properties and coupling behaviors become data points in vast chemical learning models—a striking example of the meeting point between traditional and cutting-edge research worlds.
Probably the greatest shift is the multifaceted role these compounds play in collaborative projects. Interdisciplinary teams—involving biologists, computational modelers, synthetic and analytical chemists—benefit from a common molecular language. Having a reliable, highly functionalized heterocycle as a starting point eliminates friction and keeps momentum high. It’s an understated but powerful way to make “bench-to-bedside” research more than just a slogan.
Every researcher eventually encounters the dreaded “dead reaction,” with nothing but starting material left after hours of refluxing. My own experience with aryl bromides taught me that patience and incremental optimization pay off. Heating profiles, catalyst loadings, and solvent choices all affect outcomes, but having a substrate like 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine means at least half the variables are already in your favor. The structure tolerates a broad range of conditions, which raises odds of success and lets teams explore chemical space without worrying over pesky decomposition products.
Some obstacles remain. Larger-scale couplings can introduce new challenges—stirring efficiency, transfer losses, or heat management. These emerge during scale-up, so collaboration between bench chemists and process engineers makes a real difference. The relatively high melting point and solid-state stability keep storage simple, yet practical procedures for post-reaction workup still deserve attention, especially for labs juggling several projects at once.
Resourcefulness matters, especially in budget-conscious settings. Creative chemists navigating limited funding get more mileage from robust intermediates like this one. Its availability in research quantities, respectable shelf life, and straightforward handling lower barriers to entry for smaller labs or teaching environments. Every successful coupling or library expansion validates the decision to rely on tried-and-tested building blocks.
It’s easy to speak in general terms about the popularity or utility of a core structure, but literature surveys and publication trends provide concrete backing. Over the last decade, a growing wave of synthetic papers and patents have cited pyrazolopyrimidine derivatives—including brominated versions—as crucial starting points. These are not just esoteric footnotes but key elements in many kinase inhibition studies, anti-inflammatory agent development, and agricultural chemistry programs.
Patent landscapes are crowded with claims involving substitutions at the 3-position. Medicinal chemistry success stories from biotech firms focus on brominated intermediates because their transformation to amines, aryls, or other heteroatoms leads smoothly to novel compounds, often with surprising bioactivity. In the world of combinatorial chemistry, building central libraries around robust, functionalized heterocycles speeds up screening and the all-important “hit-to-lead” journeys.
Open-source databases also shed light on real-world usage. Publicly available chemical repositories track deposits of synthetic routes, physical data, and biological evaluation, and brominated pyrazolopyrimidines crop up with regularity across thousands of entries. These databases tell the real story behind the trends: broad adoption goes hand-in-hand with documented results.
Thoughtful research practices maximize the potential while minimizing setbacks. For those new to bromo heterocycles, reference to both the chemical literature and product-specific technical sheets remains good practice. Lab safety guides should always be followed, especially to mitigate risk from dust or solvent exposure common with this class of compounds.
Teams looking to scale up their synthesis can take a few key steps:
Some researchers working with this compound have turned to greener catalysts and milder reaction conditions, responding to an industry-wide push for sustainable synthetic routes. Using recyclable palladium catalysts, water-based solvent systems, or flow chemistry setups are steps that align with environmental stewardship commitments and keep research aligned with emerging regulations.
Research thrives on smart choices and resilient materials. 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine keeps making its case for regular use in both discovery and development, thanks to a rare combination of functional group compatibility, reliable sourcing, and flexibility in transformation. This building block doesn’t offer magic shortcuts, but it does reward persistent effort with adaptable, high-value intermediates.
As innovation cycles accelerate and demands for new chemical matter only grow, scientists appreciate proven tools that keep research moving forward. 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine shows that well-designed starting materials still power both breakthrough discoveries and everyday problem solving at the cutting edge of chemistry.
